179 related articles for article (PubMed ID: 12878816)
1. [BK virus-associated nephropathy].
Kaltenis P
Medicina (Kaunas); 2003; 39(7):637-9. PubMed ID: 12878816
[TBL] [Abstract][Full Text] [Related]
2. Treatment of polyomavirus infection with cidofovir in a renal-transplant recipient.
Bjorang O; Tveitan H; Midtvedt K; Broch LU; Scott H; Andresen PA
Nephrol Dial Transplant; 2002 Nov; 17(11):2023-5. PubMed ID: 12401867
[No Abstract] [Full Text] [Related]
3. Use of cidofovir in polyomavirus BK viral nephropathy in two renal allograft recipients.
Lim WH; Mathew TH; Cooper JE; Bowden S; Russ GR
Nephrology (Carlton); 2003 Dec; 8(6):318-23. PubMed ID: 15012704
[TBL] [Abstract][Full Text] [Related]
4. Quantitative viral load monitoring and cidofovir therapy for the management of BK virus-associated nephropathy in children and adults.
Vats A; Shapiro R; Singh Randhawa P; Scantlebury V; Tuzuner A; Saxena M; Moritz ML; Beattie TJ; Gonwa T; Green MD; Ellis D
Transplantation; 2003 Jan; 75(1):105-12. PubMed ID: 12544881
[TBL] [Abstract][Full Text] [Related]
5. BK transplant nephropathy successfully treated with cidofovir.
Keller LS; Peh CA; Nolan J; Bannister KM; Clarkson AR; Faull RJ
Nephrol Dial Transplant; 2003 May; 18(5):1013-4. PubMed ID: 12686681
[No Abstract] [Full Text] [Related]
6. BK nephropathy: what is the role of antiviral therapy?
Fishman JA
Am J Transplant; 2003 Feb; 3(2):99-100. PubMed ID: 12614295
[No Abstract] [Full Text] [Related]
7. Cidofovir may be deleterious in BK virus-associated nephropathy.
Pallet N; Burgard M; Quamouss O; Rabant M; Bererhi L; Martinez F; Thervet E; Anglicheau D; Noel LH; Rouzioux C; Legendre C
Transplantation; 2010 Jun; 89(12):1542-4. PubMed ID: 20559110
[No Abstract] [Full Text] [Related]
8. Treatment of refractory BK virus-associated nephropathy with cidofovir.
Kadambi PV; Josephson MA; Williams J; Corey L; Jerome KR; Meehan SM; Limaye AP
Am J Transplant; 2003 Feb; 3(2):186-91. PubMed ID: 12614296
[TBL] [Abstract][Full Text] [Related]
9. Cidofovir may be deleterious in BK virus-associated nephropathy.
Hakeem A; Sharma H; Sharma A
Transplantation; 2011 Jan; 91(2):e11-2; author reply e12. PubMed ID: 21239956
[No Abstract] [Full Text] [Related]
10. Successful pregnancy in renal transplant recipient with previous known polyomavirus nephropathy.
Midtvedt K; Bjorang O; Letting AS
Clin Transplant; 2007; 21(4):571-3. PubMed ID: 17645722
[TBL] [Abstract][Full Text] [Related]
11. Intermediate-dose cidofovir without probenecid in the treatment of BK virus allograft nephropathy.
Araya CE; Lew JF; Fennell RS; Neiberger RE; Dharnidharka VR
Pediatr Transplant; 2006 Feb; 10(1):32-7. PubMed ID: 16499584
[TBL] [Abstract][Full Text] [Related]
12. Treatment of BK virus-associated nephropathy with Cidofovir in renal transplantation.
Cabello V; Margarit N; Díaz Pedrero M; Bernal G; Pereira P; Gentil MA
Transplant Proc; 2008 Nov; 40(9):2930-2. PubMed ID: 19010151
[TBL] [Abstract][Full Text] [Related]
13. Stabilization of renal function after the first year of follow-up in kidney transplant recipients treated for significant BK polyomavirus infection or BK polyomavirus-associated nephropathy.
Simard-Meilleur MC; Bodson-Clermont P; St-Louis G; Pâquet MR; Girardin C; Fortin MC; Cardinal H; Hébert MJ; Lévesque R; Renoult E
Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28207975
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of cidofovir treatment of polyomavirus nephropathy in kidney transplant recipients.
Hua DK; Howard K; Craig JC; Chapman JR; Wong G
Transplantation; 2012 Jan; 93(2):188-94. PubMed ID: 22186937
[TBL] [Abstract][Full Text] [Related]
15. BK virus-associated nephropathy in a kidney transplant recipient successfully treated with cidofovir, the first case in Japan.
Akioka K; Okamoto M; Ushigome H; Nobori S; Kaihara S; Yoshimura N
Int J Urol; 2008 Apr; 15(4):369-71. PubMed ID: 18380832
[TBL] [Abstract][Full Text] [Related]
16. Observations on the use of cidofovir for BK virus infection in renal transplantation.
Kuten SA; Patel SJ; Knight RJ; Gaber LW; DeVos JM; Gaber AO
Transpl Infect Dis; 2014 Dec; 16(6):975-83. PubMed ID: 25412701
[TBL] [Abstract][Full Text] [Related]
17. In kidney transplant recipients with BK polyomavirus infection, early BK nephropathy, microvascular inflammation, and serum creatinine are risk factors for graft loss.
Mohamed M; Parajuli S; Muth B; Astor BC; Panzer SE; Mandelbrot D; Zhong W; Djamali A
Transpl Infect Dis; 2016 Jun; 18(3):361-71. PubMed ID: 26998753
[TBL] [Abstract][Full Text] [Related]
18. The effect of low-dose cidofovir on the long-term outcome of polyomavirus-associated nephropathy in renal transplant recipients.
Wu SW; Chang HR; Lian JD
Nephrol Dial Transplant; 2009 Mar; 24(3):1034-8. PubMed ID: 19059933
[TBL] [Abstract][Full Text] [Related]
19. [Therapeutic possibilities for polyomavirus infections in renal transplantation].
Hurault de Ligny B; Godin M; Lobbedez T; Etienne I; El Haggan W; Pujo M; Ryckelynck JP
Presse Med; 2003 Apr; 32(14):667-8. PubMed ID: 12714908
[TBL] [Abstract][Full Text] [Related]
20. A single-centre study of adjuvant cidofovir therapy for BK virus interstitial nephritis (BKVIN) in renal allograft recipients.
Kuypers DR; Bammens B; Claes K; Evenepoel P; Lerut E; Vanrenterghem Y
J Antimicrob Chemother; 2009 Feb; 63(2):417-9. PubMed ID: 19056749
[No Abstract] [Full Text] [Related]
[Next] [New Search]
